Cel Sci Corp
CVM- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000725363
In the last 90 days, Cel Sci Corp insiders filed 1 open-market purchase and 0 sales; 40 institutions reported holding it in 13F filings for Q2 2026, worth $2.08M in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in Cel Sci Corp as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 85
- −24 vs. Q1 2022
- Shares held
- 7.67M
- −5.86M (−43.3%) vs. Q1 2022
- Total value
- $34.5M
- −$19.0M (−35.5%) vs. Q1 2022
- New holders
- 14
- 23 more added
- Sold out
- 38
- 31 more reduced
3 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CVM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 40 | $2.08M |
| Q1 2026 | 39 | $2.43M |
| Q4 2025 | 40 | $3.90M |
| Q3 2025 | 35 | $8.01M |
| Q2 2025 | 28 | $1.10M |
| Q1 2025 | 53 | $1.73M |
| Q4 2024 | 62 | $2.75M |
| Q3 2024 | 66 | $6.32M |
| Q2 2024 | 67 | $7.22M |
| Q1 2024 | 78 | $14.5M |
| Q4 2023 | 73 | $17.9M |
| Q3 2023 | 66 | $6.79M |
| Q2 2023 | 61 | $13.2M |
| Q1 2023 | 64 | $13.1M |
| Q4 2022 | 76 | $13.8M |
| Q3 2022 | 78 | $20.0M |
| Q2 2022 | 85 | $34.5M |
| Q1 2022 | 112 | $53.6M |
| Q4 2021 | 103 | $110.5M |
| Q3 2021 | 110 | $177.3M |
| Q2 2021 | 117 | $121.1M |
| Q1 2021 | 115 | $208.5M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Cel Sci Corp; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| M Holdings Securities, Inc. | 0 | $0 | 0.00% | −27,726−100.0% | Sold out |
| Alliancebernstein L.P. | 0 | $0 | 0.00% | −25,900−100.0% | Sold out |
| Aristides Capital LLC | 0 | $0 | 0.00% | −24,430−100.0% | Sold out |
| Deutsche Bank AG | 0 | $0 | 0.00% | −20,853−100.0% | Sold out |
| Virtus ETF Advisers LLC | 0 | $0 | 0.00% | −19,631−100.0% | Sold out |
| American International Group, Inc. | 0 | $0 | 0.00% | −17,848−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −17,777−100.0% | Sold out |
| State Board of Administration of Florida Retirement System | 0 | $0 | 0.00% | −15,941−100.0% | Sold out |
| Invesco Ltd. | 0 | $0 | 0.00% | −15,509−100.0% | Sold out |
| Manufacturers Life Insurance Company, The | 0 | $0 | 0.00% | −15,436−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −14,475−100.0% | Sold out |
| Voya Investment Management LLC | 0 | $0 | 0.00% | −13,851−100.0% | Sold out |
| Wolverine Trading, LLC | 0 | $0 | 0.00% | −12,557−100.0% | Sold out |
| Arizona State Retirement System | 0 | $0 | 0.00% | −11,631−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −10,056−100.0% | Sold out |
| Amalgamated Bank | 0 | $0 | 0.00% | −5,738−100.0% | Sold out |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 0 | $0 | 0.00% | −4,491−100.0% | Sold out |
| Great West Life Assurance Co | 0 | $0 | 0.00% | −2,574−100.0% | Sold out |
| Ameritas Investment Partners, Inc. | 0 | $0 | 0.00% | −2,865−100.0% | Sold out |
| Herold Advisors, Inc. | 0 | $0 | 0.00% | −1,500−100.0% | Sold out |
| Macquarie Group Ltd | 0 | $0 | 0.00% | −469−100.0% | Sold out |
| FinTrust Capital Advisors, LLC | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| Money Concepts Capital Corp | 0 | $0 | 0.00% | −40−100.0% | Sold out |
| Parametric Portfolio Associates LLC | – | – | – | – | Not filed |
| Amalgamated Financial Corp. | – | – | – | – | Not filed |
| Nauset Wealth Management. LLC | – | – | – | – | Not filed |